Biodexa Pharmaceuticals PLC (BDRX)
4.86
+0.01
(+0.21%)
USD |
NASDAQ |
Nov 14, 16:00
4.81
-0.05
(-1.03%)
After-Hours: 07:02
Biodexa Pharmaceuticals Cash and Short Term Investments (Quarterly): 6.394M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.394M |
| June 30, 2024 | 6.394M |
| December 31, 2023 | 7.606M |
| June 30, 2023 | 6.593M |
| June 30, 2023 | 6.593M |
| December 31, 2022 | 3.432M |
| June 30, 2022 | 7.790M |
| June 30, 2022 | 7.790M |
| December 31, 2021 | 13.57M |
| June 30, 2021 | 5.818M |
| June 30, 2021 | 5.818M |
| December 31, 2020 | 10.28M |
| June 30, 2020 | 5.327M |
| June 30, 2020 | 5.327M |
| December 31, 2019 | 14.33M |
| Date | Value |
|---|---|
| June 30, 2019 | 11.38M |
| June 30, 2019 | 11.38M |
| December 31, 2018 | 2.973M |
| June 30, 2018 | 5.382M |
| June 30, 2018 | 5.382M |
| December 31, 2017 | 17.84M |
| June 30, 2017 | 8.047M |
| June 30, 2017 | 8.047M |
| December 31, 2016 | 21.63M |
| June 30, 2016 | 9.727M |
| June 30, 2016 | 9.727M |
| December 31, 2015 | 23.96M |
| June 30, 2015 | 38.28M |
| June 30, 2015 | 38.28M |
| December 31, 2014 | 47.20M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.432M
Minimum
Dec 2022
14.33M
Maximum
Dec 2019
7.538M
Average
6.593M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 214.79M |
| Verona Pharma PLC | 336.04M |
| NuCana PLC | 14.72M |
| Autolus Therapeutics PLC | 705.94M |
| TC BioPharm (Holdings) PLC | 1.238M |